|
The effectiveness of bivalent clostridial and pasteurella combined vaccines in the laboratory animals
|
|
THE INCIDENCE OF CRYPTOSPORIDIUM INFECTION AMONG FRIESIAN AND BUFFALO CALVES IN MINUFIYA GOVERNORATE
|
|
COMPARE MICROSCOPY STAINING AND POLYMERASE CHAIN REACTION FOR DIAGNOSIS OF CRYPTOSPORIDIUM INFECTION AMONG FRISIAN CALVES IN MINUFIYA GOVERNORATE
|
|
D/N752 CODING CHANGE IN DNA POLYMERASE GENE (ORF30) PLAYS NO ROLE IN EQUID HERPESVIRUS TYPE 1 (EHV-1) GROWTH IN VITRO
|
|
IDENTIFICATION AND REGULATION OF EXPRESSION OF THE UL24 PROTEIN OF EQUINE HERPES VIRUS TYPE 1
|
|
IMMUNE RESPONSE OF C. PERFRINGENS TYPE A VACCINE IN CALVES
|
|
STUDIES ON ENTEROTOXAEMIA IN CALVES
|
|
Microscopic staining and Polymerase Chain Reaction for diagnosis of cryptosporidium infection among Frisian calves in Minufiya Governorate
|
|
Evaluation of Humoral Immune Response in sheep vaccinated with Montanide Gel Adjuvated Rift Valley Fever Vaccine
|
|
INVESTIGATION ON THE EFFECT OF SOME ANTIPARASITIC AND ANTIBIOTICS ON THE IMMUNE RESPONSE OF DOGS TO RABIES VACCINE
|
|
A New Trend in Donkeys Tetanus Treatment Using IgY
|
|
Direct detection of Mycobacterium avium subsp. Paratuberculosis in bovine milk by multiplex Real-time PCR
|
|
EPIDEMIOLOGICAL STUDIES ON RIFT VALLEY FEVER DISEASE IN EGYPT
|
|
The use of different diagnostic tools for Babesia and Theileria parasites in cattle in Menofia, Egypt
|
|
Effect of passive immunization by anti-gingipain IgY on periodontal health of dogs
|
|
Comparative diagnostic studies on Babesia and Theileria among cattle at Minufiya province
|
|
Experimental mice model for Giardia lamblia infection and the in-vitro and in-vivo effectiveness of anti-Giardia lamblia IgY on experimentally infected mice model
|
|
|
Anti-Candida albicans egg yolk immunoglobulin (anti-CA IgY) inhibits the adhesion of C. albicans and C. glabrata to dentures
|
|
|
Studies on the Escherichia coli virulence factors coding heat stable toxin, Verotoxin and gene for attaching and effacing associated with diarrhea in calves using PCR
|
|
In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
|
|
Molecular phylogeny of equine herpesvirus 1 isolates from onager, zebra and Thomson’s gazelle
|
|
ウマヘルペスウイルス 1 型, RacL11 および KentuckyD 株の分子生物学的特徴 (ウイルス学)
|
|
|
Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients
|
|
Anti-Candida albicans egg yolk immunoglobulin: cross activity and pilot study
|
|
|
The in-vitro effectiveness of chicken egg yolk immunoglobulins prepared against Candida albicans (anti-CA IgY).
|
|
|
Protective efficacy of anti-Candida albicans chicken egg yolk immunoglobulins (anti-CA IgY) in a murine model of oral candidiasis.
|
|
|
Molecular characterization of equine herpesvirus 1 (EHV-1) isolated from cattle indicating no specific mutations associated with the interspecies transmission.
|
|
Molecular characterization of the equine herpesvirus 1 strains RacL11 and Kentucky D.
|
|
Genetic relatedness and pathogenicity of equine herpesvirus 1 isolated from onager, zebra and gazelle
|
|
The antigenic Fractions of Candida albicans: Subcellular components, the whole cell, cell wall and cell membrane
|
|
南アフリカの野生動物に検出された新しいガンマヘルペスウイルス (ウイルス学)
|
|
|
Moleculer Biology of Equine Herpervirus 1 Pathogenesis
|
|
|
Detection of novel gammaherpesviruses in wild animals of South Africa.
|
|
Genomic analysis of equine herpesvirus 1 isolates isolated from cattle
|
|
|
Identification of genes of pathogenicity in RacL 11 and Kentucky D strains of equine herpesvirus 1 by LA-PCR RFLP
|
|
|
Molecular relationship among equine herpesvirus 1 isolates from horse, onager, zebra, and gazelle.
|
|
|
Growth and virulence alterations of equine herpesvirus 1 by insertion of a green fluorescent protein gene in the intergenic region between ORFs 62 and 63.
|
|
Virulence alteration of EHV-1 by insertion of GFP in the intergenic region between ORF 62 and 63.
|
|
|
Molecular characterization of the insertion recombinant tegument protein ORF-13 (UL47) of equine herpesvirus 1
|
|
|
Alteration of EHV-1 by insertion of GFP in the intergenic region between ORF 62 and 63.
|
|
|
Construction of recombinant EHV-1 by insertion mutation in the tegument protein (ORF13) and characterization its virological properties
|
|
|
Some Studies On Oedematous Skin Disease
|
|
|
DEVELOPMENT OF IGY ANTIBODIES FOR
CONTROL OF TETANUS
|
|
Seroprevalence and Economic Impact of Rift Valley Fever Among
Small Ruminants
|
|
Passive protection against Giardia lamblia infection in a mouse model by specific immunoglobulins from chicken egg yolk
|
|